Inventor · disambiguated record
Kenya Shitara
Also filed as: SHITARA KENYA
56 granted patents·27 pending applications·1,760 citations·filing 1987–2017
99Inventor score
Files withKYOWA HAKKO KOGYO KK42KYOWA HAKKO KIRIN CO LTD18SHITARA KENYA9MEKADA EISUKE4OCHIAI ATSUSHI2
Top patents by PatentIndex Score
83 records- 0199US5866692AProcess for producing humanized chimera antibodyKYOWA HAKKO KOGYO KK·Filed 1995·Granted Feb 2, 1999·323 cites·2 claims
- 0297US7923538B2Recombinant antibody compositionKYOWA HAKKO KIRIN CO LTD·Filed 2006·Granted Apr 12, 2011·84 cites·5 claims
- 0397US5750078AProcess for producing humanized chimera antibodyKYOWA HAKKO KOGYO KK·Filed 1995·Granted May 12, 1998·156 cites·3 claims
- 0496US6989145B2Recombinant antibody and antibody fragmentKYOWA HAKKO KOGYO KK·Filed 2001·Granted Jan 24, 2006·93 cites·37 claims
- 0595US7994290B2Effector function enhanced recombinant antibody compositionKYOWA HAKKO KIRIN CO LTD·Filed 2008·Granted Aug 9, 2011·55 cites·6 claims
- 0695US6437098B1Human chimeric antibody specific for the ganglioside GD3KYOWA HAKKO KOGYO KK·Filed 1999·Granted Aug 20, 2002·87 cites·4 claims
- 0793US8313913B2Method of enhancing of binding activity of antibody composition to Fcγ receptor IIIaNAKAMURA KAZUYASU·Filed 2009·Granted Nov 20, 2012·37 cites·1 claims
- 0893US7842797B2Human CDR-grafted antibody and antibody fragment thereofKYOWA HAKKO KIRIN CO LTD·Filed 2009·Granted Nov 30, 2010·14 cites·6 claims
- 0993US7666418B2Method for treating Th2-mediated diseaseKYOWA HAKKO KIRIN CO LTD·Filed 2005·Granted Feb 23, 2010·22 cites·32 claims
- 1093US6986890B1Anti-human VEGF receptor Flt-1 monoclonal antibodyKYOWA HAKKO KOGYO KK·Filed 1999·Granted Jan 17, 2006·100 cites·6 claims
- 1193US6872392B2Humanized antibodiesKYOWA HAKKO KOGYO KK·Filed 2002·Granted Mar 29, 2005·44 cites·3 claims
- 1293US5830470AHumanized antibodies to ganglioside GM2KYOWA HAKKO KOGYO KK·Filed 1993·Granted Nov 3, 1998·112 cites·3 claims
- 1392US7504104B2Human CDR-grafted antibody and antibody fragment thereofKYOWA HAKKO KOGYO KK·Filed 2002·Granted Mar 17, 2009·28 cites·19 claims
- 1492US7498415B2Recombinant antibody against human insulin-like growth factorKYOWA HAKKO KOGYO KK·Filed 2004·Granted Mar 3, 2009·48 cites·11 claims
- 1592US7479371B2Method of judging leukemia, pre-leukemia or aleukemic malignant blood disease and diagnostic thereforUNIV TOKAI·Filed 2003·Granted Jan 20, 2009·96 cites·14 claims
- 1691US7253263B1Complementarity determining region-grafted antibody against ganglioside GD3 and derivative of antibody against ganglioside GD3KYOWA HAKKO KOGYO KK·Filed 2000·Granted Aug 7, 2007·37 cites·12 claims
- 1790US7691568B2Antibody composition-containing medicamentKYOWA HAKKO KIRIN CO LTD·Filed 2003·Granted Apr 6, 2010·39 cites·5 claims
- 1890US7064191B2Process for purifying antibodyKYOWA HAKKO KOGYO KK·Filed 2001·Granted Jun 20, 2006·89 cites·8 claims
- 1990US7052693B2Anti-human VEGF receptor FLT-1 monoclonal antibodyKYOWA HAKKO KOGYO KK·Filed 2002·Granted May 30, 2006·20 cites·8 claims
- 2089US7438911B2Antibody against human insulin-like growth factorKYOWA HAKKO KOGYO KK·Filed 2003·Granted Oct 21, 2008·33 cites·13 claims
- 2187US7851601B2Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factorKYOWA HAKKO KIRIN CO LTD·Filed 2008·Granted Dec 14, 2010·7 cites·13 claims
- 2286US5807548AMethod of treating cancer using a chimera antibodyKYOWA HAKKO KOGYO KK·Filed 1995·Granted Sep 15, 1998·30 cites·1 claims
- 2382US8632996B2Method for producing recombinant antibody and antibody fragment thereofSHITARA KENYA·Filed 2012·Granted Jan 21, 2014·4 cites·28 claims
- 2482US4892935AAnti-human pulmonary carcinoma monoclonal antibodyKYOWA HAKKO KOGYO KK·Filed 1987·Granted Jan 9, 1990·47 cites·3 claims
- 2581US8883981B2Recombinant antibody compositionSHITARA KENYA·Filed 2010·Granted Nov 11, 2014·3 cites·6 claims
- 2680US6423511B1Humanized antibodiesKYOWA HAKKO KOGYO KK·Filed 1999·Granted Jul 23, 2002·42 cites·7 claims
- 2779US8197814B2Method for treating the Th2-mediated diseaseSHITARA KENYA·Filed 2010·Granted Jun 12, 2012·3 cites·32 claims
- 2879US7045129B2Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3KYOWA HAKKO KOGYO KK·Filed 2002·Granted May 16, 2006·2 cites·2 claims
- 2977US8481039B2Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factorMEKADA EISUKE·Filed 2012·Granted Jul 9, 2013·2 cites·19 claims
- 3077US7615215B2Anti-human VEGF receptor Flt-1 monoclonal antibodyKYOWA HAKKO KIRIN CO LTD·Filed 2006·Granted Nov 10, 2009·1 cites·9 claims
- 3176US8491902B2Medicament comprising recombinant antibody against chemokine receptor CCR4SHITARA KENYA·Filed 2004·Granted Jul 23, 2013·6 cites·17 claims
- 3276US6965024B2Process for producing humanized chimera antibodyKYOWA HAKKO KOGYO KK·Filed 2002·Granted Nov 15, 2005·1 cites·12 claims
- 3376US6495666B2Polypeptide composing human chimeric antibodyKYOWA HAKKO KOGYO KK·Filed 2001·Granted Dec 17, 2002·1 cites·2 claims
- 3474US8163282B2Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factorMEKADA EISUKE·Filed 2009·Granted Apr 24, 2012·1 cites·7 claims
- 3574US8143058B2Human CDR-grafted antibody and antibody fragment thereofSHITARA KENYA·Filed 2010·Granted Mar 27, 2012·1 cites·5 claims
- 3674US5939532AHumanized antibodies to ganglioside GM2KYOWA HAKKO KOGYO KK·Filed 1995·Granted Aug 17, 1999·22 cites·2 claims
- 3773US7404953B2Methods using eosinophil-specific apoptosis inducerKYOWA HAKKO KOGYO KK·Filed 2001·Granted Jul 29, 2008·6 cites·12 claims
- 3872US6042828AHumanized antibodies to ganglioside GM2KYOWA HAKKO KOGYO KK·Filed 1996·Granted Mar 28, 2000·16 cites·10 claims
- 3968US10590203B2Human CDR-grafted antibody and antibody fragment thereofKYOWA HAKKO KIRIN CO LTD·Filed 2017·Granted Mar 17, 2020·0 cites·5 claims
- 4068US9051371B2Human CDR-grafted antibody and antibody fragment thereofKYOWA HAKKO KIRIN CO LTD·Filed 2014·Granted Jun 9, 2015·0 cites·4 claims
- 4167US8173781B2Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factorMEKADA EISUKE·Filed 2009·Granted May 8, 2012·0 cites·5 claims
- 4266US9475886B2Recombinant antibody compositionKYOWA HAKKO KIRIN CO LTD·Filed 2014·Granted Oct 25, 2016·0 cites·8 claims
- 4366US8900584B2Human CDR-grafted antibody and antibody fragment thereofKYOWA HAKKO KIRIN CO LTD·Filed 2013·Granted Dec 2, 2014·0 cites·6 claims
- 4466US8093361B2Anti-perp antibodyOCHIAI ATSUSHI·Filed 2005·Granted Jan 10, 2012·1 cites·33 claims
- 4564US6617160B1Anti-human VEGF receptor Flt-1 monoclonal antibodyKYOWA HAKKO KOGYO KK·Filed 1998·Granted Sep 9, 2003·24 cites·10 claims
- 4664US2010150917A1Method of Depleting Regulatory T CellKYOWA HAKKO KIRIN CO LTD·Filed 2009·Application pending·0 cites
- 4764US2006057139A1Process for producing humanized chimera antibodyKYOWA HAKKO KOGYO KK·Filed 2005·Application pending·0 cites
- 4863US2006058512A1Process for producing humanized chimera antibodyKYOWA HAKKO KOGYO KK·Filed 2005·Application pending·0 cites
- 4963US2007073043A1Process for producing humanized chimera antibodyKYOWA HAKKO KOGYO KK·Filed 2005·Application pending·0 cites
- 5062US9675625B2Medicament comprising recombinant antibody against chemokine receptor CCR4KYOWA HAKKO KIRIN CO LTD·Filed 2013·Granted Jun 13, 2017·0 cites·18 claims
Showing the top 50 of 83 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Kenya Shitara files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →